Karen J. Coffman
Karen J. Coffman publishes mostly in Molecular Biology, Organic Chemistry and Physiology, on topics such as Alzheimer's disease research and treatments, Computational Drug Discovery Methods and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #2,273,213 of 7,710,434 ranked researchers
- Rank in United States
- #679,198 of 1,627,098
- Works
- 41
- Citations
- 2.9k
- Citations per work
- 69.7
What does Karen J. Coffman research?
Karen J. Coffman's work is mostly in Medicine (21%), Biochemistry, Genetics and Molecular Biology (20%), Chemistry (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1434.2%
- Physical Sciences1024.8%
- Chemistry818.8%
- Computer Science26.0%
- Health Sciences921.3%
- Medicine921.3%
- Life Sciences819.7%
- 1Molecular Biology20% of their works
- 2Organic Chemistry19% of their works
- 3Physiology8% of their works
- 4Infectious Diseases7% of their works
- 5Computational Theory and Mathematics6% of their works
- 6Pharmacology6% of their works
Research topics
- Alzheimer's disease research and treatments
- Computational Drug Discovery Methods
- Cholinesterase and Neurodegenerative Diseases
- Synthesis of heterocyclic compounds
- SARS-CoV-2 and COVID-19 Research
- Chemical Synthesis and Analysis
- Neuroscience and Neuropharmacology Research
- Synthesis and Reactions of Organic Compounds
Which keywords describe Karen J. Coffman's research?
The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Acetylcholinesterase, Cholinesterase Inhibitors, Heterocycles, Molecular Docking, Synthesis and Virtual Screening.
- Synaptic Plasticity
- Oxazolones
- Imidazoles
- SARS-CoV-2
- Coronavirus
- Virtual Screening
- Molecular Docking
- Cholinesterase Inhibitors
- Tau Pathology
- Amyloid Hypothesis
- Acetylcholinesterase
- Heterocycles
- Synthesis
- Annulation
- Ketene Dithioacetal
- Drug Discovery
- Neurotransmission
- Peptide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Amyloid Hypothesis91 topic
- Tau Pathology91 topic
- Acetylcholinesterase71 topic
- Cholinesterase Inhibitors71 topic
- Heterocycles72 topics
- Molecular Docking71 topic
- Synthesis72 topics
- Virtual Screening71 topic
- Annulation41 topic
- Coronavirus41 topic
- Ketene Dithioacetal41 topic
- SARS-CoV-241 topic
- Drug Discovery31 topic
- Imidazoles31 topic
- Neurotransmission31 topic
- Oxazolones31 topic
- Peptide Synthesis31 topic
- Synaptic Plasticity31 topic
Where does Karen J. Coffman work?
Karen J. Coffman's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Karen J. Coffman have?
OpenAlex counts 41 works and 2,857 citations for Karen J. Coffman, an h-index of 16, ranking #2,273,213 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karen J. Coffman. Posts are plain text and can be reported.